The global molecular imaging market was valued at USD 2.19 billion in 2024 and is expected to grow to USD 2.32 billion in 2025, reaching USD 3.46 billion by 2032. This reflects a compound annual growth rate (CAGR) of 5.9% during the forecast period. In 2024, North America held the largest share of the molecular imaging market, accounting for 63.83% of the total market.

The molecular imaging market is experiencing steady growth as demand increases for accurate, non-invasive diagnostic tools across various medical fields, including oncology, cardiology, and neurology. This advanced imaging approach enables real-time visualization of biological processes at the molecular and cellular levels, enhancing early disease detection and personalized treatment planning. Technological innovations, along with rising investment in healthcare infrastructure and research, are supporting broader adoption. As awareness of precision medicine continues to grow, the molecular imaging market is expected to expand further in both developed and emerging regions.

Continue reading for more details:

**https://www.fortunebusinessinsights.com/molecular-imaging-market-112879**

Market Segmentation

• The molecular imaging market is segmented by technology into PET, SPECT, and multimodal imaging systems.
• By application, the molecular imaging market includes oncology, cardiology, neurology, and inflammatory disorders.
• Segmentation by end user comprises hospitals, diagnostic imaging centers, and research institutions in the molecular imaging market.
• The molecular imaging market is also categorized by radiotracer type, including FDG, Technetium-99m, and novel tracers.
• Regional segmentation in the molecular imaging market allows for analysis of growth trends and adoption patterns across key markets.

List Of Key Molecular Imaging Companies Profiled:

• GE Healthcare (U.S.)
• Siemens Healthineers AG (Germany)
• Koninklijke Philips N.V. (Netherlands)
• Shimadzu Corporation (Japan)
• CANON MEDICAL SYSTEMS CORPORATION (Japan)
• Bruker (U.S.)
• Lantheus Holdings, Inc. (U.S.)
• Segami Corporation (U.S.)